New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 18, 2014
16:32 EDTNRXNephrogenex initiates pivotal oral Pyridorin Phase 3 study
NephroGenex announced it has initiated patient enrollment in the first of two pivotal Phase 3 studies in the PIONEER program for oral Pyridorin. The trial will evaluate the safety and efficacy of Pyridorin in slowing disease progression in patients with diabetic nephropathy.
News For NRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for NRX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use